|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03320 CHINARES PHARMA
Nominal 
4.650 -0.055 (-1.169%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 20,476,332 | 17,535,514 | 15,549,886 | 10,821,138 |
| Net Cash from / (used in) Investing Activities | -- | (10,066,751) | (8,887,771) | (2,067,287) | (819,239) |
| Net Cash from / (used in) Financing Activities | -- | (10,957,407) | (16,838,454) | (4,065,319) | (9,126,070) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (547,826) | (8,190,711) | 9,417,280 | 875,829 |
| Cash & Cash Equivalents at beginning of period | -- | 16,424,739 | 24,650,670 | 15,223,726 | 14,315,973 |
| Effect of Foreign Exchange Rate Changes | -- | (33,104) | (35,220) | 9,664 | 31,924 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 15,843,809 | 16,424,739 | 24,650,670 | 15,223,726 |
| Remarks: | Real time quote last updated: 25/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,186,632 |
| %Change | 5.264% |
| EPS / (LPS) | RMB 0.350 |
| NBV Per Share (¥) | RMB 8.404 |